Cyclacel Pharmaceuticals, Inc. SEC 10-Q Report — TradingView News
Cyclacel Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company focused on developing innovative cancer medicines, has released its Form 10-Q report for the second quarter of 2025. The report provides a detailed overview of the company’s financial performance and key business activities for the six months ended June 30, 2025. Financial Highlights Revenues: $0, The company reported no…

